Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L.

Journal of Natural Medicines

Volumn 66, Issue 4, 2012, Pages 614-621

  Susanti, Siti ^a,b   Iwasaki, Hironori ^b   Itokazu, Yukiyoshi ^b   Nago, Mariko ^b   Taira, Naoyuki ^b   Saitoh, Seikoh ^b   Oku, Hirosuke ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Arctigenin; Cytotoxicity; Extract; Herbal; Tumor

Indexed keywords

ACORUS CALAMUS EXTRACT; ANTINEOPLASTIC AGENT; ARCTIGENIN; ARCTIUM LAPPA EXTRACT; CARUM CARVI EXTRACT; CASPASE 3; CITRUS RETICULATE EXTRACT; CITRUS UNSHIU EXTRACT; LIGUSTICUM WALLICHII EXTRACT; PHYLLOSTACHYS NIGRA EXTRACT; PLANT EXTRACT; PRUNUS MUME EXTRACT; SOUR ORANGE EXTRACT; STAUROSPORINE; UNCLASSIFIED DRUG;

ACORUS CALAMUS; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARCTIUM LAPPA; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARAWAY; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIGUSTICUM; LIGUSTICUM WALLICHII; LIVER CANCER; LUNG CANCER; MANDARIN; MEDICINAL PLANT; NONHUMAN; PHYLLOSTACHYS; PHYLLOSTACHYS NIGRA; PHYTOCHEMISTRY; PRUNUS; PRUNUS MUME; SATSUMA; SOUR ORANGE; STOMACH CANCER; TUMOR SPECIFIC CYTOTOXICITY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARCTIUM; CELL LINE, TUMOR; FURANS; HEP G2 CELLS; HUMANS; LIGNANS; PLANT EXTRACTS;

EID: 84863469149     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-012-0628-0     Document Type: Article

References (42)

1. Fabricant DS, Farnsworth NR (2001) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109(1):69-75 (Pubitemid 32303231)
2. Hoareau L, DaSilva EJ (1999) Medicinal plants: a re-emerging health aid. Electron J Biotechnol 2:56-70 (Pubitemid 38982427)
3. Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, Wang WB (2010) Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. BMC Cancer 10:175
4. Ruan WJ, Lai M, Zhou JG (2006) Anticancer effects of Chinese herbal medicine, science or myth? J Zhejiang Univ Sci B 7(12):1006-1014
5. Alphen JP, Aris A, Dharmananda S (1995) The book oriental medicine: an illustrated guide to the Asian arts of healing. Serindia Publications, London
6. Cragg GM, Newman DJM, Snader KM (1997) Natural products in drug discovery and development. J Nat Prod 60:52-60 (Pubitemid 27052102)
7. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (2005) Cancer incidence in five continents, vol VIII. IARC Scientific Publication, Lyon
8. Murphy SL (2000) Deaths: final data for 1998. Natl Vital Stat Rep 48:1-105
9. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK (2000) The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398-2424 (Pubitemid 30247142)
10. Skeel RT (2003) Handbook of cancer chemotherapy. Lippincott Williams and Wilkins, Philadelphia
11. Camp-Sorrell D (2000) Chemotherapy: toxicity management. In: Yarbro CH, Frogge MH, Goodman M, Groenwald SL (eds) Cancer nursing: principles and practice, 5th edn. Jones and Bartlett Publishers, Sudbury
12. Chabner B, Longo DL (2005) Cancer chemotherapy and biotherapy: principles and practice, 4th edn. Lippincott Williams & Wilkins, Philadelphia. ISBN 0781756286
13. Hirsch J (2006) An anniversary for cancer chemotherapy. J Am Med Assoc 296(12):1518-1520 (Pubitemid 44465516)
14. Joensuu H (2008) Systemic chemotherapy for cancer: from weapon to treatment. Lancet Oncol 9(3):304 (Pubitemid 351722950)
15. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569-1575 (Pubitemid 28520643)
16. Buchanan DR, White JD, O'Mara AM, Kalaghan JW, Smith WB, Minasian LM (2005) Research-design issues in cancer-symptommanagement trials using complementary and alternative medicine: lesson from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 23(27):6682-6689 (Pubitemid 46190263)
17. Umehara K, Sugama A, Kuroyanagi M, Ueno A, Taki T (1993) Studies on differentiation-inducers from Arctium fructus. Chem Pharm Bull 41:1774-1779 (Pubitemid 23351528)
18. Wang P, Henning SM, Heber D (2010) Limitation of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenol. PloS ONE 5(4):e10202
19. Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S (2004) Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92:291-295 (Pubitemid 38610112)
20. Park KI, Park HS, Kang SR, Nagappan A, Lee DH, Kim JA, Han DY, Kim GS (2011) Korean Scutellaria baicalensis water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells. J Ethnopharmacol 133:634-641
21. Ranga RS, Sowmyalakshmi S, Burikhanov R, Akbarsha MA, Chendil D (2005) A herbal medicine for the treatment of lung cancer. Mol Cell Biochem 280:125-133 (Pubitemid 41829808)
22. Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H, Tanaka T (2001) Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone induced pulmonary tumorigenesis in mice. Cancer Lett 174(2):41-150
23. Tanaka T, Yasui Y, Ishigamori-Suzuki R, Oyama T (2008) Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice. Nutr Cancer 60:70-80
24. Murakami A, Nakamura Y, Ohto Y, Yano M, Koshiba T, Koshimizu K, Tokuda H, Nishino H, Ohigashi H (2000) Suppressive effects of citrus fruits on free radical generation and nobiletin, and anti-inflammatory polymethoxyflavonoid. Biofactors 12(1-4):187-192 (Pubitemid 32107406)
25. Tanaka T, Kohno H, Murakami M, Shimada R, Kagami S, Sumida T, Azuma Y, Ogawa H (2000) Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin. Int J Cancer 88(1):146-150
26. Garcia OB, Castillo J, Marin FR, Ortuno A, Del Rio AJ (1997) Uses and properties of Citrus flavonoids. J Agric Food Chem 45(12):4505-4515
27. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi H (2006) Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 66:1751-1757 (Pubitemid 43259960)
28. Cho MK, Jang YP, Kim YC, Kim SG (2004) Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-α inhibition. Int Immunopharmacol 4:1419-1429 (Pubitemid 39094415)
29. Tamayo C, Richardson MA, Diamond S, Skoda I (2000) The chemistry and biological activity of herbs used in Flor-EssenceTM Herbal Tonic and EssiacTM. Phytother Res 14:1-14 (Pubitemid 30087943)
30. Zhao F, Wang L, Liu K (2009) In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 122:457-462
31. Jeong JB, Hong SC, Jeong HJ, Koo JS (2011) Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells. Int Immunopharmacol 11:1573-1577
32. Moritani S, Nomura M, Takeda Y, Miyamoto KI (1996) Cytotoxic components of Bardanae Fructus (Goboshi). Biol Pharm Bull 19(11):1515-1517 (Pubitemid 26403265)
33. Hausott B, Greger H, Marian B (2003) Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells. J Cancer Res Clin Oncol 129:569-576 (Pubitemid 37363596)
34. Yoo JH, Lee HJ, Kang K, Jho EH, Kim CY, Baturen D, Tunsag J, Nho CW (2010) Lignans inhibit cell growth via regulation of Wnt/b-catenin signaling. Food Chem Toxicol 48:2247-2252
35. Matsumoto T, Hosono-Nishiyama K, Yamada H (2006) Antiproliferative and apoptotic effects of butyrolactone lignans from Arctium lappa on leukemic cells. Planta Med 72:276-278
36. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y (1994) Induction of a common pathways of apoptosis by Staurosporine. Exp Cell Res 211:314-321 (Pubitemid 24174963)
37. Wang Y, Yang H, Liu H, Huang J, Song X (2009) Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study. BMC Cancer 9:174. doi: 10.1186/1471-2407-9-174
38. Entschladen F, Drell TL 4th, Lang K, Joseph J, Zaenker KS (2005) Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development. Curr Pharm 3(11):403-411 (Pubitemid 40277866)
39. Zhang YX, Yu SB, Ou-Yang JP, Xia D, Wang M, Li JR (2005) Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine. Acta Pharmacol Sin 26(11):1365-1372 (Pubitemid 41607010)
40. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555 (Pubitemid 24363798)
41. Courage C, Snowden R, Gescher A (1996) Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. Br J Cancer 74:1199-1205 (Pubitemid 26360107)
42. Kim YJ, Hwang JH, Cha M, Yoon MY, Son ES, Tomida A, Ko B, Song SW, Shin-Ya K, Hwang Y, Park HR (2010) Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. J Cell Physiol 224:33-40